Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00744965 · ClinicalTrials.gov registry record · Phase 4
Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 395
- Enrollment target
NCT00744965 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 395 participants.
The verdict
NCT00744965, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 395 participants
- Enrollment target
Study Summary
This is a randomized prospective trial which addresses the question of whether use of an oral hypoglycemic agent as an adjunct to diet therapy in women with mild gestational diabetes will result in achieving euglycemia in a shorter period of time and, in turn, result in less frequent maternal and neonatal morbidities. This study is designed to test the hypothesis that in women with mild GDM, use of Glyburide in addition to diet and nutritional counseling lowers mean infant birth weight by 200 grams as compared with diet and nutritional counseling alone.
Interventions
- DRUG Placebo
- DRUG Glyburide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 395 participants |
| Start Date | 2008-09-16 |
| Est. Completion | 2016-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00744965
The ClinicalTrials.gov registry entry for NCT00744965 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 395 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00744965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00744965 about?
NCT00744965 is a clinical study titled "Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo". This is a randomized prospective trial which addresses the question of whether use of an oral hypoglycemic agent as an adjunct to diet therapy in women with mild gestational diabetes will result in achieving euglycemia in a shorter period of time and, in turn, result in less frequent maternal and ne...
What is the current status of trial NCT00744965?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 395 participants. The study started on 2008-09-16. Estimated completion is 2016-01.
What interventions are being tested in trial NCT00744965?
The interventions under investigation include: Placebo (DRUG), Glyburide (DRUG).
Who is sponsoring clinical trial NCT00744965?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.